查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
誘導多能幹細胞 (iPSC) 市場：按細胞衍生、按應用、按國家、按地區 - 行業分析、市場規模、市場份額、預測 2023-2030
市場調查報告書
商品編碼
1290848

誘導多能幹細胞 (iPSC) 市場：按細胞衍生、按應用、按國家、按地區 - 行業分析、市場規模、市場份額、預測 2023-2030

Induced Pluripotent Stem Cell (iPSC) Market with COVID-19 Impact Analysis, By Derived Cell, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 402 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022 年誘導多能幹細胞 (iPSC) 市場規模將達到 20.053 億美元，2023 年至 2030 年復合年增長率為 7.1%

誘導多能幹細胞 (iPSC) 市場 - 市場動態

對疫苗生產的需求不斷增長，特別是在大流行之後，以及對 iPSC 領域投資的增加是推動 iPSC 市場快速增長的一些因素。

這次大流行還凸顯了基於細胞的療法對疾病治療的重要性。iPSC 提供了可再生的細胞來源，可以分化為用於治療應用的各種細胞類型。這包括可能使用 iPSC 開發基於細胞的療法來治療肺損傷等與 COVID-19 相關的並發症。根據世界衛生組織的數據，慢性阻塞性肺疾病（COPD）是全球第三大死亡原因，2019 年有 323 萬人死亡。許多政府已經認識到 iPSC 技術的潛力，並啟動了資助計劃來支持研究和商業化工作。iPSC 衍生細胞為疫苗生產提供了一致且可擴展的平台，從而實現更快、更高效的疫苗生產過程。

誘導多能幹細胞 (iPSC) 市場 - 關鍵見解

  • 根據我們的研究分析師的分析，全球誘導多能幹細胞（iPSC）市場預計在預測期內（2023-2030年）每年都會顯著增長。
  • 由於可持續增長意識的增強，預計誘導多能幹細胞 (iPSC) 行業將大幅增長
  • 按類型細分，預計心肌細胞將在 2022 年佔據最大的市場份額
  • 從應用來看，藥物開發和發現將成為2022年的主要市場。
  • 按地區劃分，北美將成為 2022 年最大的收入來源。

誘導多能幹細胞 (iPSC) 市場細分分析：

全球誘導多能幹細胞（iPSC）市場根據細胞來源、應用和地區進行細分。

市場根據細胞來源分為三類：肝細胞、成纖維細胞。肝細胞、成纖維細胞、羊水細胞、心肌細胞等。心肌細胞在市場上佔據主導地位。患者特異性 iPSC 衍生心肌細胞 (iPSC-CM) 對於心血管疾病建模、研究人類發育的早期階段、加速藥物毒性預測測試以及潛在推進再生療法提供了一個實驗平台。

市場按應用分為兩類：製造、學術研究、藥物開發和發現、毒性篩查和再生醫學。藥物開發和發現在市場中佔據主導地位，預計在預測期內將保持其主導地位。誘導多能幹細胞 (iPSC) 技術正在徹底改變醫學，使我們能夠探索疾病機制和新的治療分子靶點，並為藥物發現和藥物開發的概念驗證研究提供機會。

誘導多能幹細胞 (iPSC) 市場 - 地理洞察

從地理上看，該市場遍布北美、拉丁美洲、歐洲、亞太地區、中東和非洲。由於慢性病的流行以及乾細胞在治療中的使用，預計北美將主導誘導多能幹細胞（iPSC）市場。根據美國疾病控制與預防中心的數據，2018 年，普通人群中 51.8%（1.29 億）的非住院成年人至少患有 10 種選定的慢性病中的一種。對解決慢性病的先進和創新療法的需求正在推動該地區 iPSC 市場的增長。總體而言，歐洲和亞洲也積極參與 iPSC 研發。

誘導多能幹細胞 (iPSC) 市場 - 競爭格局：

美國、韓國、日本、英國和中國已成為乾細胞治療的前五個國家，因為它們願意推進該領域並為患者提供創新治療。iPS 細胞市場的知名企業只是其中的幾個例子。全球其他公司、學術機構和研究機構也積極從事iPS細胞研究、產品開發和臨床試驗。例如，2021 年 1 月 27 日，Thermo Fisher Scientific 使用同種異體工作流程為細胞療法開發人員開發了一種用於人類 T 淋巴細胞 (T 細胞) 發育和擴增的新培養基。新產品發布、分銷網絡開發、研發支出以及併購是公司擴大影響力和市場份額的一些關鍵方法。

最近的發展

2021 年 11 月，人類 iPS 細胞（誘導多能幹細胞）技術領先公司 Ncardia（比利時戈斯利）宣布與投資平台 Kiniciti（美國紐約）建立合作夥伴關係。

研究的主要特點

  • 本研究報告提供了以2022年為基準年的誘導多能幹細胞（iPSC）市場規模、複合年增長率、市場估計和預測（2023-2030年）。
  • 該研究報告讓客戶深入了解誘導多能幹細胞 (iPSC) 市場的最新趨勢。
  • 該研究報告闡明了不同細分市場/國家的潛在增長機會，並描述了誘導多能幹細胞 (iPSC) 市場有吸引力的投資主張矩陣。
  • 綜合報告揭示了誘導多能幹細胞 (iPSC) 市場的新投資機會、現有企業面臨的挑戰以及持續增長動力
  • 研究範圍詳細討論了 COVID-19 對誘導多能幹細胞 (iPSC) 市場規模、預測、複合年增長率和市場動態的影響。它還涵蓋了對新冠疫情後誘導多能幹細胞 (iPSC) 市場的深入見解。
  • 為了向本報告的用戶提供誘導多能幹細胞（iPSC）市場的全面了解，還包括誘導多能幹細胞（iPSC）市場的競爭格局和關鍵創新者分析。
  • 該研究涵蓋了增長前景映射分析，並根據市場規模、增長率和吸引力對所有行業領域進行了基準測試。
  • 該報告提供了主要市場進入者的詳細公司概況，有助於了解在誘導多能幹細胞 (iPSC) 市場運營的公司的財務信息和戰略舉措。
  • 此外，報告還揭示了全球和區域市場主要參與者的重大收購和兼併、合作和合資、初創企業、研發和區域擴張。
  • 本研究報告主要面向該行業的各個利益相關者，如供應商、投資者、新進入者、分銷商和財務分析師。

目錄

第一章誘導多能幹細胞（iPSC）市場概述

  • 調查範圍

第二章執行摘要

  • 市場細分
  • 競爭考慮

第三章誘導多能幹細胞（iPSC）的主要市場趨勢

  • 市場驅動力
  • 誘導多能幹細胞（iPSC）市場限制因素
  • 誘導多能幹細胞 (iPSC) 的市場機會
  • 誘導多能幹細胞（iPSC）市場的未來趨勢

第 4 章 誘導多能幹細胞 (iPSC) 行業調查

  • PEST分析
  • 波特五力分析
  • 繪製增長前景
  • 監管框架分析

第五章誘導多能幹細胞（iPSC）市場：COVID-19 的影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析

第六章誘導多能幹細胞（iPSC）市場格局

  • 誘導多能幹細胞 (iPSC) 市場份額分析，2022 年
  • 主要製造商的細分數據
    • 現有公司分析
    • 啟動分析

7.誘導多能幹細胞（iPSC）市場——按細胞衍生

  • 概述
    • 細分市場份額分析（按衍生單元）
    • 標準鋼誘導多能幹細胞 (iPSC)
    • 非磁性誘導多能幹細胞（iPSC）

8 誘導多能幹細胞 (iPSC) 市場 - 按應用

  • 概述
    • 按應用劃分的細分市場份額分析
    • 土地
    • 離岸

第九章誘導多能幹細胞 (iPSC) 市場 - 按地區

  • 介紹
  • 北美
    • 概述
    • 北美領先的誘導多能幹細胞 (iPSC) 製造商
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲領先的誘導多能幹細胞 (iPSC) 製造商
    • 德國
    • 意大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 其他
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區領先的誘導多能幹細胞 (iPSC) 製造商
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳大利亞
    • 泰國
    • 印度尼西亞
    • 菲律賓
    • 其他
  • 拉丁美洲
    • 概述
    • 拉丁美洲領先的誘導多能幹細胞 (iPSC) 製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他
  • 中東和非洲
    • 概述
    • 中東和非洲領先的誘導多能幹細胞 (iPSC) 製造商
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 其他

第10章主要供應商分析-誘導多能幹細胞（iPSC）行業

  • 比賽儀表板
  • 公司簡介
    • Lonza
    • Axol Biosciences Ltd.
    • Evotec SE
    • Hitachi Ltd.
    • Merck KGaA
    • REPROCELLS, Inc.
    • Fate Therapeutics
    • Thermo Fisher Scientific, Inc.
    • StemCellsFactory III
    • Applied StemCells, Inc.

第十一章 分析師的全面看法

Product Code: ANV1294

REPORT HIGHLIGHT

Induced Pluripotent Stem Cell (iPSC) Market size was valued at USD 2,005.3 million in 2022, expanding at a CAGR of 7.1% from 2023 to 2030.

Induced Pluripotent Stem cells (iPSC) are derived from skin or blood cells that have been reprogrammed back into an embryonic-like pluripotent state that enables the development of an unlimited source of any type of human cell needed for therapeutic purposes. For example, iPSC can be prodded into becoming beta islet cells to treat diabetes, blood cells to create new blood free of cancer cells for a leukemia patient, or neurons to treat neurological disorders. iPSC have certain advantages over other stem cell types in models of regenerative medicine and wound healing. Because they are derived from adult somatic cells, and not embryos, iPSC are not associated with the ethical dilemmas surrounding the use of embryonic stem cells.

Induced Pluripotent Stem Cell (iPSC) Market- Market Dynamics:

Rising demand for vaccine production especially after the onslaught of the pandemic, and increasing investments in the iPSC sector are some of the factors contributing towards rapid iPSC market growth.

The pandemic has also emphasized the importance of cell-based therapies for treating diseases. iPSCs offer a renewable source of cells that can be differentiated into various cell types for therapeutic applications. This includes the potential use of iPSCs for developing cell-based therapies to treat COVID-19-related complications, such as lung damage. According to World health organization, Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide, causing 3.23 million deaths in 2019. Many governments recognize the potential of iPSC technology and have initiated funding programs to support research and commercialization efforts. iPSC-derived cells provide a consistent and scalable platform for vaccine production, enabling faster and more efficient vaccine manufacturing processes.

Induced Pluripotent Stem Cell (iPSC) Market- Key Insights:

  • As per the analysis shared by our research analyst, the global Induced Pluripotent Stem Cell (iPSC) market is estimated to grow annually at a CAGR of around XX% over the forecast period (2023-2030)
  • The Induced Pluripotent Stem Cell (iPSC) industry is projected to grow at a significant rate due to the growing awareness of sustainable growth
  • Based on type segmentation, Cardiomyocytes were predicted to show maximum market share in the year 2022
  • Based on Application segmentation, Drug development, and discovery were the leading in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Induced Pluripotent Stem Cell (iPSC) Market- Segmentation Analysis:

  • The Global Induced Pluripotent Stem Cell (iPSC) Market is segmented on the basis of derived cells, Application, and Region.
  • The market is divided into three categories based on derived cells: Hepatocytes, Fibroblasts. Amniotic Cells, Cardiomyocytes, and Others. Cardiomyocytes dominate the market. Patient-specific iPSC-derived Cardiomyocytes (iPSC-CMs) offer an attractive experimental platform to model cardiovascular diseases, study the earliest stages of human development, accelerate predictive drug toxicology tests, and advance potential regenerative therapies.
  • The market is divided into two categories based on application: Manufacturing, Academic Research, Drug Development & Discovery, Toxicity Screening, and Regenerative Medicine. Drug development and discovery dominate the market and are likely to maintain its dominance during the forecast period. Induced pluripotent stem cell (iPSC) technology is revolutionizing medical science, allowing the exploration of disease mechanisms and novel therapeutic molecular targets, and offering opportunities for drug discovery and proof-of-concept studies in drug development.

Induced Pluripotent Stem Cell (iPSC) Market- Geographical Insights:

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America is expected to dominate the Induced Pluripotent Stem Cell (iPSC market, due to the prevalence of chronic disease and the use of Stem Cell in their treatment. According to center of disease control and prevention, in 2018, 51.8% (129 million) of civilian, noninstitutionalized adults had been diagnosed with at least 1 of 10 selected chronic conditions. iPSCs hold tremendous potential for developing personalized therapies and disease modeling in these areas. The demand for advanced treatments and innovative therapies to address chronic diseases drives the growth of the iPSC market in this region. Overall, Europe and Asia, are also actively participating in iPSC research and development.

Induced Pluripotent Stem Cell (iPSC) Market- Competitive Landscape:

The United States, South Korea, Japan, the United Kingdom, and China have emerged as the top five countries for stem cell treatment, recognitions to their commitment to advancing the field and providing innovative treatment options for patients. There are just a few examples of prominent players in the iPSC market. Other companies, academic institutions, and research organizations worldwide are actively engaged in iPSC research, product development, and clinical trials. For example, 27 Jan,2021 Thermo Fisher Scientific has developed a new medium for the development and expansion of human T lymphocytes (T-cells) for cell therapy developers using allogeneic workflows. Some of the primary techniques used by corporations to strengthen their reach and expand their market share include new product launches, distribution network development, R&D spending, and mergers and acquisitions.

Recent Developments:

In November 2021, Ncardia (Gosselies, Belgium), a leading human-induced pluripotent stem cell (iPSC) technology company, has recently announced their partnership with investment platform Kiniciti (NY, USA) - a collaboration which will facilitate the development of innovative iPSC-derived advanced therapies.

Key features of the study:

  • This proposed research study on Induced Pluripotent Stem Cell (iPSC) market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the Induced Pluripotent Stem Cell (iPSC) market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Induced Pluripotent Stem Cell (iPSC) market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Induced Pluripotent Stem Cell (iPSC) market
  • Impact of COVID-19 on Induced Pluripotent Stem Cell (iPSC) market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Induced Pluripotent Stem Cell (iPSC) market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the Induced Pluripotent Stem Cell (iPSC) market, we have also included competitive landscape and key innovator analysis for the Induced Pluripotent Stem Cell (iPSC) market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Induced Pluripotent Stem Cell (iPSC) market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global Induced Pluripotent Stem Cell (iPSC) market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INDUCED PLURIPOTENT STEM CELL (IPSC) MARKET KEY PLAYERS

  • Lonza
  • Axol Biosciences Ltd.
  • Evotec SE
  • Hitachi Ltd.
  • Merck KGaA
  • REPROCELLS, Inc.
  • Fate Therapeutics
  • Thermo Fisher Scientific, Inc.
  • StemCellsFactory III
  • Applied StemCells, Inc.

GLOBAL INDUCED PLURIPOTENT STEM CELL (IPSC) MARKET, BY DERIVED CELL

  • Hepatocytes
  • Fibroblasts
  • Amniotic Cells
  • Cardiomyocytes
  • Others

GLOBAL INDUCED PLURIPOTENT STEM CELL (IPSC) MARKET, BY APPLICATION

  • Manufacturing
  • Academic Research
  • Drug Development & Discovery
  • Toxicity Screening
  • Regenerative Medicine

GLOBAL INDUCED PLURIPOTENT STEM CELL (IPSC) MARKET, BY REGION

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Russia
    • Netherlands
    • Sweden
    • Poland
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • South Korea
    • Japan
    • Australia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Turkey
    • Algeria
    • Egypt
    • Rest of MEA

Table of Contents

1. Induced Pluripotent Stem Cell (iPSC) Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Induced Pluripotent Stem Cell (iPSC) Market Snippet by Derived Cells
    • 2.1.2. Induced Pluripotent Stem Cell (iPSC) Market Snippet by Application
    • 2.1.3. Induced Pluripotent Stem Cell (iPSC) Market Snippet by Country
    • 2.1.4. Induced Pluripotent Stem Cell (iPSC) Market Snippet by Region
  • 2.2. Competitive Insights

3. Induced Pluripotent Stem Cell (iPSC) Key Market Trends

  • 3.1. Induced Pluripotent Stem Cell (iPSC) Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Induced Pluripotent Stem Cell (iPSC) Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Induced Pluripotent Stem Cell (iPSC) Market Opportunities
  • 3.4. Induced Pluripotent Stem Cell (iPSC) Market Future Trends

4. Induced Pluripotent Stem Cell (iPSC) Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Induced Pluripotent Stem Cell (iPSC) Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Induced Pluripotent Stem Cell (iPSC) Market Landscape

  • 6.1. Induced Pluripotent Stem Cell (iPSC) Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Induced Pluripotent Stem Cell (iPSC) Market - By Derived cells

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Derived cells, 2022 & 2030 (%)
    • 7.1.2. Standard Steel Induced Pluripotent Stem Cell (iPSC)
    • 7.1.3. Non-magnetic Induced Pluripotent Stem Cell (iPSC)

8. Induced Pluripotent Stem Cell (iPSC) Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Onshore
    • 8.1.3. Offshore

9. Induced Pluripotent Stem Cell (iPSC) Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Induced Pluripotent Stem Cell (iPSC) Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Induced Pluripotent Stem Cell (iPSC) Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Induced Pluripotent Stem Cell (iPSC) Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Induced Pluripotent Stem Cell (iPSC) Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Induced Pluripotent Stem Cell (iPSC) Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Induced Pluripotent Stem Cell (iPSC) Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Lonza
    • 10.2.2. Axol Biosciences Ltd.
    • 10.2.3. Evotec SE
    • 10.2.4. Hitachi Ltd.
    • 10.2.5. Merck KGaA
    • 10.2.6. REPROCELLS, Inc.
    • 10.2.7. Fate Therapeutics
    • 10.2.8. Thermo Fisher Scientific, Inc.
    • 10.2.9. StemCellsFactory III
    • 10.2.10. Applied StemCells, Inc.

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Induced Pluripotent Stem Cell (iPSC) Market: Derived cells Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Derived cells
  • TABLE Global Induced Pluripotent Stem Cell (iPSC) Market, by Derived cells 2018-2030 (USD Million)
  • TABLE Induced Pluripotent Stem Cell (iPSC) Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Induced Pluripotent Stem Cell (iPSC) Market, by Application 2018-2030 (USD Million)
  • TABLE Induced Pluripotent Stem Cell (iPSC) Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Induced Pluripotent Stem Cell (iPSC) Market, by Region 2018-2030 (USD Million)
  • TABLE North America Induced Pluripotent Stem Cell (iPSC) Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Induced Pluripotent Stem Cell (iPSC) Market, by Derived cells, 2018-2030 (USD Million)
  • TABLE North America Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Induced Pluripotent Stem Cell (iPSC) Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Induced Pluripotent Stem Cell (iPSC) Market, by Derived cells, 2018-2030 (USD Million)
  • TABLE Europe Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Induced Pluripotent Stem Cell (iPSC) Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Induced Pluripotent Stem Cell (iPSC) Market, by Derived cells, 2018-2030 (USD Million)
  • TABLE Asia Pacific Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Induced Pluripotent Stem Cell (iPSC) Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Induced Pluripotent Stem Cell (iPSC) Market, by Derived cells, 2018-2030 (USD Million)
  • TABLE Latin America Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Market, by Derived cells, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2018-2030 (USD Million)

List of Figures

  • FIGURE Induced Pluripotent Stem Cell (iPSC) Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Derived cells segment market share analysis, 2022 & 2030
  • FIGURE Derived cells segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Technology segment market share analysis, 2022 & 2030
  • FIGURE Technology segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Induced Pluripotent Stem Cell (iPSC) Market share and leading players, 2022
  • FIGURE Europe Induced Pluripotent Stem Cell (iPSC) Market share and leading players, 2022
  • FIGURE Asia Pacific Induced Pluripotent Stem Cell (iPSC) Market share and leading players, 2022
  • FIGURE Latin America Induced Pluripotent Stem Cell (iPSC) Market share and leading players, 2022
  • FIGURE Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Induced Pluripotent Stem Cell (iPSC) Market share analysis by country, 2022
  • FIGURE Germany Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Induced Pluripotent Stem Cell (iPSC) Market share analysis by country, 2022
  • FIGURE India Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Induced Pluripotent Stem Cell (iPSC) Market share analysis by country, 2022
  • FIGURE Brazil Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Market share analysis by country, 2022
  • FIGURE Saudi Arabia Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)